Detalhe da pesquisa
1.
Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer.
CA Cancer J Clin
; 73(5): 516-523, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114458
2.
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer.
CA Cancer J Clin
; 73(6): 590-596, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358310
3.
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
CA Cancer J Clin
; 69(4): 305-343, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116423
4.
Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
Cancer
; 130(9): 1702-1710, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140735
5.
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
Int J Cancer
; 152(2): 123-136, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904874
6.
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Int J Cancer
; 153(9): 1623-1634, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539667
7.
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Cancer
; 129(23): 3724-3734, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651160
8.
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Cancer Control
; 30: 10732748231185047, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339926
9.
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus.
Curr Treat Options Oncol
; 23(12): 1748-1760, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272049
10.
Diagnosis of digestive system tumours.
Int J Cancer
; 148(5): 1040-1050, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32674220
11.
Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care.
J Natl Compr Canc Netw
; 19(2): 122-125, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545684
12.
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
Clin Trials
; 18(1): 51-60, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998522
13.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
JAMA
; 325(13): 1277-1286, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821899
14.
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Int J Cancer
; 147(10): 2948-2956, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449172
15.
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer.
Oncologist
; 25(5): 404-413, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848314
16.
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer.
Clin Gastroenterol Hepatol
; 18(12): 2717-2723.e3, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811950
17.
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors.
Oncologist
; 24(3): 319-326, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018131
18.
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer.
Cancer Causes Control
; 30(7): 757-765, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31104167
19.
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Cancer
; 124(15): 3118-3126, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905927
20.
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Oncologist
; 23(11): 1319-1327, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866946